431 results on '"Döring, Yvonne"'
Search Results
2. Targeting immune cell recruitment in atherosclerosis
3. Somatic RIT1 delins in arteriovenous malformations hyperactivate RAS-MAPK signaling amenable to MEK inhibition
4. Early intermittent cholesterol exposure accelerates atherosclerosis: an oscillating amplifier calling for preemptive control
5. A cost-effective sequencing method for genetic studies combining high-depth whole exome and low-depth whole genome
6. Identification of a non-canonical chemokine-receptor pathway suppressing regulatory T cells to drive atherosclerosis
7. GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease
8. Clinical phenotype of adolescent and adult patients with extracranial vascular malformation
9. (Multi-) omics studies of ILC2s in inflammation and metabolic diseases.
10. Targeting platelet-derived CXCL12 impedes arterial thrombosis
11. A systematic review of the safety and efficacy of currently used treatment modalities in the treatment of patients with PIK3CA-related overgrowth spectrum
12. Endothelial ACKR3 drives atherosclerosis by promoting immune cell adhesion to vascular endothelium
13. Gut microbial metabolite imidazole propionate impairs endothelial cell function and promotes the development of atherosclerosis
14. Lack of Formyl-peptide Receptor 1 Mitigates Atherosclerosis in Hyperlipidemic Mice
15. Targeting the chemokine network in atherosclerosis
16. Non‐Hotspot PIK3CA Variants Have Higher Variant Allele Frequency and are More Common in Syndromic Vascular Malformations.
17. Mex3a Protects Against Atherosclerosis: Evidence From Mice and Humans.
18. MicroRNA-26b protects against MASH development and can be efficiently targeted with lipid nanoparticles
19. Non-activatable mutant of inhibitor of kappa B kinase α (IKKα) exerts vascular site-specific effects on atherosclerosis in Apoe-deficient mice
20. Adipocyte calcium sensing receptor is not involved in visceral adipose tissue inflammation or atherosclerosis development in hyperlipidemic Apoe−/− mice
21. ILC2-mediated immune crosstalk in chronic (vascular) inflammation
22. Beyond association: high neutrophil counts are a causal risk factor for atherosclerotic cardiovascular disease
23. Parkes Weber Syndrome: Contribution of the Genotype to the Diagnosis
24. Simultaneous assessment of mechanical and electrical function in Langendorff-perfused ex-vivo mouse hearts
25. Targeting a cell-specific microRNA repressor of CXCR4 ameliorates atherosclerosis in mice
26. Examining ChemR23 orchestrated cross talk of perivascular adipose tissue and arterial vasculature in atherosclerosis
27. microRNA-26b protects against mash development and can be efficiently targeted with lipid nanoparticles
28. Loss of B cell-ACKR3 reduces atherosclerosis by decreasing plasma cells and pro-inflammatory antibody production
29. ChemR23 expression protects against smooth muscle cell phenotype switching in atherosclerosis
30. CCR8-driven immune functions on group 2 innate lymphoid cells (ILC2s) in atherosclerosis
31. Endothelial CaSR induces atherosclerosis by promoting cell adhesion and local inflammation
32. Molecular drivers of medial arterial calcification in lower extremity artery disease
33. NETs-Induced Thrombosis Impacts on Cardiovascular and Chronic Kidney Disease
34. Human Neutrophil Peptide 1 Limits Hypercholesterolemia-induced Atherosclerosis by Increasing Hepatic LDL Clearance
35. Chemokines and galectins form heterodimers to modulate inflammation
36. Endotoxinemia Accelerates Atherosclerosis Through Electrostatic Charge–Mediated Monocyte Adhesion
37. Neutrophil Extracellular Traps Participate in Cardiovascular Diseases: Recent Experimental and Clinical Insights
38. B-Cell–Specific CXCR4 Protects Against Atherosclerosis Development and Increases Plasma IgM Levels
39. Native, Intact Glucagon-Like Peptide-1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions
40. Association of sex and cardiovascular risk factors with atherosclerosis distribution pattern in lower extremity peripheral artery disease
41. GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease
42. WEGS: a cost-effective sequencing method for genetic studies combining high-depth whole exome and low-depth whole genome
43. Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease
44. Hematopoietic ChemR23 (Chemerin Receptor 23) Fuels Atherosclerosis by Sustaining an M1 Macrophage-Phenotype and Guidance of Plasmacytoid Dendritic Cells to Murine Lesions—Brief Report
45. CXCL12 Derived From Endothelial Cells Promotes Atherosclerosis to Drive Coronary Artery Disease
46. Neonatal obstructive nephropathy induces necroptosis and necroinflammation
47. Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using 111In-tilmanocept
48. How slimming regulatory T cells limit atherosclerosis: Mechanistic insights into T cell lipid metabolism
49. Synchronized integrin engagement and chemokine activation is crucial in neutrophil extracellular trap–mediated sterile inflammation
50. Double-Strand DNA Sensing Aim2 Inflammasome Regulates Atherosclerotic Plaque Vulnerability
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.